tiprankstipranks
Trending News
More News >
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
Advertisement

Ocular Therapeutix (OCUL) Similar Stocks

Compare
1,462 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ocular Therapeutix
$11.48
$2.43B
-8.99
3.61%
13 Buy
0 Hold
0 Sell
Strong Buy
89bio
$14.84
$2.20B
81.42%
5 Buy
4 Hold
0 Sell
Moderate Buy
Beam Therapeutics
$24.77
$2.83B
10.09%
11 Buy
2 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$67.56
$2.85B
53.91%
6 Buy
0 Hold
0 Sell
Strong Buy
ARS Pharmaceuticals
$9.39
$927.98M
-40.09%
5 Buy
0 Hold
0 Sell
Strong Buy
Belite Bio, Inc. ADR
$98.00
$2.86B
44.56%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OCUL
Ocular Therapeutix
11.48
0.40
3.61%
ETNB
89bio
14.84
6.85
85.73%
BEAM
Beam Therapeutics
24.77
2.27
10.09%
TARS
Tarsus Pharmaceuticals
67.52
22.79
50.95%
SPRY
ARS Pharmaceuticals
8.98
-5.29
-37.07%
BLTE
Belite Bio, Inc. ADR
98.00
37.45
61.85%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis